Global and China Vaccine Contract Manufacturing Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Vaccine Contract Manufacturing industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Mereck KGaA (Germany)

    • Pfizer Inc (US)

    • Ajinomoto Althea, Inc

    • Lonza

    • Catalent, Inc

    • Servier Laboratories (France)

    • Merck KGaA

    • Fujifilm Diosynth Biotechnologies USA, Inc

    • Cytovance Biologics

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Attenuated Vaccine

    • Inactivated Vaccine

    • Subunit vaccines

    • Toxoid Vaccines

    • DNA Vaccines

    Application:

    • Pharmaceutical Companies

    • Biotech Companies

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Vaccine Contract Manufacturing Industry Overview

      • 1.1.1 Vaccine Contract Manufacturing Market Scope and Market Segments

      • 1.1.2 Vaccine Contract Manufacturing Industry Characteristics

      • 1.1.3 Global and China Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Vaccine Contract Manufacturing Production Value and Growth Rate (2017-2028)

    • 1.2 Global Vaccine Contract Manufacturing Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Attenuated Vaccine

      • 1.2.2 Inactivated Vaccine

      • 1.2.3 Subunit vaccines

      • 1.2.4 Toxoid Vaccines

      • 1.2.5 DNA Vaccines

    • 1.3 Global Vaccine Contract Manufacturing Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Pharmaceutical Companies

      • 1.3.2 Biotech Companies

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Vaccine Contract Manufacturing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Vaccine Contract Manufacturing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Vaccine Contract Manufacturing Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Vaccine Contract Manufacturing Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Vaccine Contract Manufacturing Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Vaccine Contract Manufacturing Industry Porter's Five Forces Model Analysis

      • 2.2.3 Vaccine Contract Manufacturing Industry PEST Analysis

    • 2.3 Vaccine Contract Manufacturing Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Vaccine Contract Manufacturing Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Vaccine Contract Manufacturing Industry

    Chapter 3 Global and China Vaccine Contract Manufacturing Market, by Manufacturer

    • 3.1 Global and China Vaccine Contract Manufacturing Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Vaccine Contract Manufacturing Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Vaccine Contract Manufacturing Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Vaccine Contract Manufacturing Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Vaccine Contract Manufacturing Market Top 3 Players

    Chapter 4 Global and China Vaccine Contract Manufacturing Market, by Type (2017-2028)

    • 4.1 Vaccine Contract Manufacturing Market Trend, by Type

    • 4.2 Global Vaccine Contract Manufacturing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Vaccine Contract Manufacturing Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Vaccine Contract Manufacturing Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Vaccine Contract Manufacturing Price Trend, by Type (2017-2028)

    • 4.3 China Vaccine Contract Manufacturing Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Vaccine Contract Manufacturing Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Vaccine Contract Manufacturing Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Vaccine Contract Manufacturing Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Vaccine Contract Manufacturing Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Vaccine Contract Manufacturing Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Vaccine Contract Manufacturing Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Vaccine Contract Manufacturing Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Vaccine Contract Manufacturing Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Vaccine Contract Manufacturing Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Vaccine Contract Manufacturing Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Vaccine Contract Manufacturing Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Vaccine Contract Manufacturing Market Analysis

    • 7.1 North America Vaccine Contract Manufacturing Market, by Type

    • 7.2 North America Vaccine Contract Manufacturing Market, by Application

    • 7.3 North America Vaccine Contract Manufacturing Market Analysis and Forecast, by Country

      • 7.3.1 United States Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Vaccine Contract Manufacturing Market Analysis

    • 8.1 Europe Vaccine Contract Manufacturing Market, by Type

    • 8.2 Europe Vaccine Contract Manufacturing Market, by Application

    • 8.3 Europe Vaccine Contract Manufacturing Market Analysis and Forecast, by Country

      • 8.3.1 Germany Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Vaccine Contract Manufacturing Market Analysis

    • 9.1 APAC Vaccine Contract Manufacturing Market, by Type

    • 9.2 APAC Vaccine Contract Manufacturing Market, by Application

    • 9.3 APAC Vaccine Contract Manufacturing Market Analysis and Forecast, by Country

      • 9.3.1 China Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Vaccine Contract Manufacturing Market Analysis

    • 10.1 Latin America, Middle East and Africa Vaccine Contract Manufacturing Market, by Type

    • 10.2 Latin America, Middle East and Africa Vaccine Contract Manufacturing Market, by Application

    • 10.3 Latin America, Middle East and Africa Vaccine Contract Manufacturing Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Vaccine Contract Manufacturing Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Vaccine Contract Manufacturing Company Profiles

      • 11.1 Mereck KGaA (Germany)

        • 11.1.1 Mereck KGaA (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Mereck KGaA (Germany) Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.1.3 Mereck KGaA (Germany) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Pfizer Inc (US)

        • 11.2.1 Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Pfizer Inc (US) Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.2.3 Pfizer Inc (US) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Ajinomoto Althea, Inc

        • 11.3.1 Ajinomoto Althea, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Ajinomoto Althea, Inc Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.3.3 Ajinomoto Althea, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Lonza

        • 11.4.1 Lonza Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Lonza Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.4.3 Lonza Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Catalent, Inc

        • 11.5.1 Catalent, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Catalent, Inc Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.5.3 Catalent, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Servier Laboratories (France)

        • 11.6.1 Servier Laboratories (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Servier Laboratories (France) Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.6.3 Servier Laboratories (France) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Merck KGaA

        • 11.7.1 Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Merck KGaA Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.7.3 Merck KGaA Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Fujifilm Diosynth Biotechnologies USA, Inc

        • 11.8.1 Fujifilm Diosynth Biotechnologies USA, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.8.3 Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Cytovance Biologics

        • 11.9.1 Cytovance Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Cytovance Biologics Vaccine Contract Manufacturing Product Profiles, Application and Specification

        • 11.9.3 Cytovance Biologics Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Vaccine Contract Manufacturing Industry Investment Prospect and Risk Assessment

    • 12.1 Vaccine Contract Manufacturing Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Vaccine Contract Manufacturing Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Production Value and Growth Rate (2017-2028)

    • Figure China Vaccine Contract Manufacturing Production Value and Growth Rate (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Attenuated Vaccine (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Inactivated Vaccine (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Subunit vaccines (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Toxoid Vaccines (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of DNA Vaccines (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Pharmaceutical Companies (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Biotech Companies (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Vaccine Contract Manufacturing Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Vaccine Contract Manufacturing Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Vaccine Contract Manufacturing Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Vaccine Contract Manufacturing Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Vaccine Contract Manufacturing Market Share, by Manufacturer in 2021

    • Figure Global and China Vaccine Contract Manufacturing Market Share, by Manufacturer in 2022

    • Table Global Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Value, by Type (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Value Share, by Type (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Price Trend, by Type (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Value, by Type (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Value Share, by Type (2017-2028)

    • Figure China Vaccine Contract Manufacturing Price Trend, by Type (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Value, by Application (2017-2028)

    • Table Global Vaccine Contract Manufacturing Sales Value Share, by Application (2017-2028)

    • Figure Global Vaccine Contract Manufacturing Sales Value Share, by Application (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Value, by Application (2017-2028)

    • Table China Vaccine Contract Manufacturing Sales Value Share, by Application (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Value Share, by Application (2017-2028)

    • Figure China Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • Figure North America Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Vaccine Contract Manufacturing Production, Import, Consumption and Export (2017-2022)

    • Table North America Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table North America Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure North America Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table North America Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table North America Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure North America Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure United States Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure United States Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Canada Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Table Europe Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table Europe Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure Europe Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table Europe Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table Europe Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure Europe Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure Germany Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure UK Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure UK Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure France Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure France Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Italy Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Spain Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Poland Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Russia Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Table APAC Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table APAC Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure APAC Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table APAC Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table APAC Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure APAC Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure China Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Japan Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure India Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure India Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Vaccine Contract Manufacturing Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Vaccine Contract Manufacturing Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Vaccine Contract Manufacturing Sales Value and Growth Rate (2017-2028)

    • Table Mereck KGaA (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mereck KGaA (Germany) Product Profiles, Application and Specification

    • Table Mereck KGaA (Germany) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Inc (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Inc (US) Product Profiles, Application and Specification

    • Table Pfizer Inc (US) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ajinomoto Althea, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ajinomoto Althea, Inc Product Profiles, Application and Specification

    • Table Ajinomoto Althea, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lonza Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lonza Product Profiles, Application and Specification

    • Table Lonza Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Catalent, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Catalent, Inc Product Profiles, Application and Specification

    • Table Catalent, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Servier Laboratories (France) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Servier Laboratories (France) Product Profiles, Application and Specification

    • Table Servier Laboratories (France) Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck KGaA Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck KGaA Product Profiles, Application and Specification

    • Table Merck KGaA Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fujifilm Diosynth Biotechnologies USA, Inc Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fujifilm Diosynth Biotechnologies USA, Inc Product Profiles, Application and Specification

    • Table Fujifilm Diosynth Biotechnologies USA, Inc Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cytovance Biologics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cytovance Biologics Product Profiles, Application and Specification

    • Table Cytovance Biologics Vaccine Contract Manufacturing Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.